Mitochondrial dysfunction as a mechanism involved in the pathogenesis of Cirrhosisassociated cholemic nephropathy

Publish Year: 1398
نوع سند: مقاله کنفرانسی
زبان: English
View: 351

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

TOXICOLOGY15_127

تاریخ نمایه سازی: 15 بهمن 1398

Abstract:

Cholemic nephropathy (CN) is a clinical complication associated with cholestasis and chronicliver diseases. CN could lead to renal failure and need for kidney transplantation if not appropriately managed. On the other hand, although the clinical features of CN are well described, there is no clear idea on the precise cellular and molecular mechanisms of CN. The current study was designed to evaluate kidney mitochondrial function in cholestasis-associated CN. Rats underwent bile duct ligation (BDL) surgery, and kidney mitochondria were isolated at scheduled time intervals (14, 28, and 42 days after BDL operation). Several mitochondrial indices including mitochondrial permeabilization and swelling, glutathione and ATP content, mitochondrial depolarization, and lipid peroxidation were evaluated. Renal tissue markers of oxidative stress along with tissue histopathological changes and serum biochemistry were also analyzed. Severe kidney tissue histopathological alterations including interstitial inflammation, necrosis, and Bowman capsule dilation were detected in the BDL animals. Moreover, drastic elevation in renal fibrosis and collagen deposition was detected in BDL rats. Oxidative stress markers were also significantly enhanced in the kidney tissue of BDL animals. On the other hand, it was found that mitochondrial indices of functionality were significantly deteriorated in BDL rats. These data introduce mitochondrial dysfunction and energy metabolism disturbances as a fundamental mechanism involved in the pathogenesis of bile acids-associated renal injury during cholestasis.

Authors

Reza Heidari

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz Iran

Leila Mandegani

Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University ofMedical Sciences, Shiraz Iran

Vahid Ghanbarinejad

Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University ofMedical Sciences, Shiraz Iran

Asma Siavashpour

Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University ofMedical Sciences, Shiraz Iran

Mohammad Mehdi Ommati

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz Iran- Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University ofMedical Sciences, Shiraz Iran

Asma Najibi

Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University ofMedical Sciences, Shiraz Iran